Circular Code Biology
Shanghai
About Circular Code Biology
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2023)
- Website: circodebio.cn
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/circular-code-biology-81 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.